Search - tctmd.com

Displaying 461 - 480 of 493

Sort: Relevancy | Date

News Daily News

CoreValve在高风险患者中的生存益处到2年时依然持续存在

July 07, 2015

News Industry News

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

June 24, 2015

News Industry News

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

June 22, 2015

News Industry News

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

June 16, 2015

News Daily News

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

Caitlin E. Cox

June 15, 2015

News Industry News

TAVR program raises margin 350% by befriending rivals

June 15, 2015

News Daily News

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Caitlin E. Cox

June 15, 2015

News Daily News

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

Caitlin E. Cox

June 15, 2015

Presentation ARCH 2015

ARCH 2015 Keynote Address: The Future of Interventional Cardiology

Presenter: Martin B. Leon

April 10, 2015

Presentation TVT 2014

A Citizen of the World and Frequent TAVR Proctor

Presenter: Eberhard Grube

June 07, 2014

Presentation TVT 2014

An Interventionalist from London, UK

Presenter: Martyn R. Thomas

June 07, 2014

Presentation TVT 2014

A Surgeon from Dallas, Texas

Presenter: Michael J. Mack

June 07, 2014

Presentation TVT 2014

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Presenter: Larry L. Wood

June 07, 2014

Presentation TVT 2014

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

Presenter: Nicolo Piazza

June 07, 2014

Presentation TVT 2014

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

Presenter: A. Pieter Kappetein

June 07, 2014

Presentation TVT 2014

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

Presenter: David J. Cohen

June 07, 2014

Presentation TCT 2013

First Prize: Percutaneous Treatment of Aortic Annulus Rupture During Transcatheter Aortic Valve Implantation

Presenter: Andrea Pacchioni

November 01, 2013

News Conference News TCT 2013

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

Advertisement

CoreValve在高风险患者中的生存益处到2年时依然持续存在

First North American Trial Results Reinforce the Safety and Hemodynamic Performance of Sorin’s Solo Smart Pericardial Aortic Valve

Boston Scientific Initiates Global Study To Assess EMBLEM™ Subcutaneous Implantable Defibrillator (S-ICD) In Primary Prevention Patients With Low Ejection Fraction

Juventas Therapeutics Granted FDA Fast Track Designation and Phase 2b Protocol Allowance for Novel Heart Failure Gene Therapy

即便经验更丰富，经心尖TAVR带给患者的生活质量也并不好于外科手术

TAVR program raises margin 350% by befriending rivals

Incluso con Más Experiencia la TAVR Transapical No ofrece una Mejor Calidad de Vida que la Cirugía

Even With More Experience, Transapical TAVR Offers No Better QoL Than Surgery

ARCH 2015 Keynote Address: The Future of Interventional Cardiology

A Citizen of the World and Frequent TAVR Proctor

An Interventionalist from London, UK

A Surgeon from Dallas, Texas

The Daunting Task of Explaining High TAVR Costs to Practitioners, Hospital Administrators, and Healthcare Systems

Are Reimbursement Patterns Directly Affecting TAVR Clinical Usage in Europe?

TAVR is not Cost Effective Compared with Surgery (in Most Patients)!

The TAVR Economic Value Proposition The Impact of Valve Costs, Complications, QOL Benefits, and Reimbursement Strategies

First Prize: Percutaneous Treatment of Aortic Annulus Rupture During Transcatheter Aortic Valve Implantation

Memories of TCT 1988 and Beyond: Julio C. Palmaz, MD

Innovation in Intervention: Perspectives from Industry

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content